７－（メチルアミノ）ピラゾロ［１，５－Ａ］ピリミジン－３－カルボキサミド化合物

Title:

７－（メチルアミノ）ピラゾロ［１，５－Ａ］ピリミジン－３－カルボキサミド化合物

Document Type and Number:

Japanese Patent JP2023515774

Kind Code:

A

Abstract:

本発明は、乾癬、全身性エリテマトーデス、または１型糖尿病の治療に有用な、Ｒが、（ＩＩ）、（ＩＩＩ）、もしくは（ＩＶ）である式（Ｉ）の化合物、またはその薬学的に許容される塩を提供する。TIFF2023515774000050.tif112121

More Like This:

WO/2011/163430	POLYMORPHS OF OSI-906
WO/2004/046150	2-SUBSTITUTED TRIAZOLOPYRIMIDINES, METHODS AND INTERMEDIATE PRODUCTS FOR THE PRODUCTION THEREOF, THE USE OF THE SAME FOR CONTROLLING PATHOGENIC FUNGI, AND AGENTS CONTAINING SAID COMPOUNDS
JP2020516669	Liver X receptor (LXR) regulator

Inventors:

Blaish, Thomas John
Chen, Zhaogen
Jessop, Theodore Curtis

Application Number:

JP2022548684A

Publication Date:

April 14, 2023

Filing Date:

February 05, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Eli Lilly and Company

International Classes:

C07D487/04; A61K31/519; A61P3/10; A61P17/06; A61P37/06

Attorney, Agent or Firm:

Yamato Kento
Shinagawa
Wu Yingyan
Sei Morimoto
Nobuhiko Akiyama

Previous Patent: antithymocyte globulin

Next Patent: Impact resistant wrappable corrugated multi-layer woven sleeve and method of construction